About this trial
The goal of this clinical trial is to learn about the effects of the combination of ketamine and realtime functional magnetic resonance imaging (fMRI) neurofeedback training in individuals with cocaine use disorder. The main questions the investigators aim to answer are:
* Can the investigators observe a positive, significant effect on percentage of cocaine use days of both interventions combined as well as stand alone interventions? * Is there a significant transfer effect of the neurofeedback training? * Is there a significant, ketamine-dependent change in glutamate levels in the nucleus accumbens?
Participants will be given ketamine and a realtime fMRI neurofeedback training. Both interventions are placebo-controlled. The investigators will compare the four intervention groups to investigate the effects of the stand-alone effects of the intervention and the combination of it.
Eligibility criteria
Qualifiers
Informed Consent as documented by signature
Male and female cocaine users 18 to 55 years of age
diagnostic and statisical manual (DSM)-5 diagnosis of CUD
Willingness to comply with the study protocol as explained by investigator
Disqualifiers
Current or lifetime psychotic disorders
History of severe substance-induced psychosis
Current or lifetime bipolar I or II disorders
Current suicidality
Trial design
Treatments tested in this trial
- Ketamine
- Placebo
- real-time fMRI neurofeedback training
- sham real-time fMRI neurofeedback training
Treatment groups
Sponsors and collaborators
Dr. med. Marcus Herdener
Lead sponsor
Psychiatric University Hospital, Zurich
Sponsor institution
University of Zurich
Collaborator
University of Vienna
Collaborator
University of Campania Luigi Vanvitelli
Collaborator